Patent · US Active

Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

US11291662B2 · kind B2 · utility

4Cited by

264References

4Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Patricia Hurter · Harvard, US
William Rowe · Medford, US
Christopher R. Young · Waltham, US
Adriana Costache · Cambridge, US
Patrick R. Connelly · Harvard, US
Mariusz Krawiec · Marlborough, US
Yuchuan Gong · Waukegan, US
Yushi Feng · Zionsville, US
Martin Trudeau · Shannon, US

Key dates

Filing date	Dec 5, 2019
Grant date	Apr 5, 2022
Priority date	—
Expiry date	Dec 5, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.